A novel Peng’s test in reducing bile leakage after partial hepatectomy for hepatocellular carcinoma: From an animal study to a clinical cohort Propensity score matching comparative study

Author:

Mo Shutian,He Yongfei,Zhu Guangzhi,Su Hao,Han Chuangye,Ye Xinping,Liao Xiwen,Yang Chengkun,Liang Tianyi,Chen Zijun,Wei Yongguang,Wei Zhongliu,Luo Jianzhu,Nong JusenORCID,Lau Wan Yee,Peng TaoORCID

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,Surgery

Reference32 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J. Clin.,2018

2. [Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)];Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese j. hepatol.,2020

3. Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma;Liu;J. Exp. Clin. Cancer Res. : CR (Clim. Res.),2019

4. Trends in surgical results of hepatic resection for hepatocellular carcinoma: 1,000 consecutive cases over 20 years in a single institution;Yamashita;Am. J. Surg.,2014

5. Management of post-hepatectomy complications;Jin;World J. Gastroenterol.,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3